Blog - Page 857 of 5752 - QualityStocks

WednesdayJan 04, 2023 11:15 am

Dosing Begins in Lexaria Bioscience Corp. (NASDAQ: LEXX) Human Clinical Study, Evaluating DehydraTECH(TM)-Nicotine Against Leading Nicotine Oral Pouch Brands

The 36-person human pharmacokinetic randomized, double-blind, cross-over study NIC-H22-1 will compare its patented DehydraTECH(TM)-nicotine to leading nicotine pouches On! and Zyn The white pouch oral delivery of nicotine is thought to avoid harmful lung outcomes that smokers and vapers experience The global nicotine pouch market was valued at $2.33 billion in 2020 and is expected to reach $21.84 billion by 2027, driven by an increase in the number of consumers seeking alternative forms of nicotine that do not involve lung exposure Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, announced that dosing has commenced for its human…

WednesdayJan 04, 2023 10:50 am

QualityStocksNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Set to Begin IGC-AD1 Phase 2 Trials at Sites Throughout Canada

India Globalization Capital (NYSE American: IGC) today announced its receipt of a no objection letter from Health Canada for approval of its “Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial of the Safety and Efficacy of IGC-AD1 on Agitation in Participants with Dementia due to Alzheimer’s Disease.” The letter provides the acknowledgement of IGC-AD1’s drug candidacy and the authority to proceed with phase 2 trials in Canada. “We are pleased to have received this no objection letter from Health Canada, which allows us to begin phase 2 trials on our drug formulation IGC-AD1 at sites throughout Canada,” said Ram Mukunda, CEO…

WednesdayJan 04, 2023 10:37 am

QualityStocksNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Announces Integration of IPT Carbonation Process into Crawford Project

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF), a company focused on advancing the next generation of nickel-sulphide projects, today announced that its latest test work results support the incorporation of carbon capture and storage into the Crawford Project. According to the update, Canada Nickel’s In-Process Tailings (“IPT”) Carbonation process is a novel method for accelerated carbon capture and storage that the company believes has transformative potential. The latest test work confirms that existing process streams can be utilized for IPT Carbonation, which Canada Nickel believes should allow it to be timely and cost effectively engineered and incorporated into the flowsheet. “We…

WednesdayJan 04, 2023 10:30 am

SideChannel Inc. (SDCH) YOY Revenue Growth Underscores Increasing Popularity of vCISO, Cybersecurity Software Services

Companies that experience data breaches face, on average, $4.35 million in consequential costs, demonstrating the importance of an effective cybersecurity response Small to medium-sized businesses (“SMBs”) generally find the costs of hiring full-time cybersecurity experts to be prohibitive, making it difficult for them to effectively protect themselves from potential cyber crimes Virtual chief information security officer (“vCISO”) services are filling the breach with expert cybersecurity consultancy provided on a contract basis that is far more affordable than a full-time hire Cybersecurity services and technology provider SideChannel Inc. provides vCISO consultancy as well as proprietary Enclave software that addresses access control…

WednesdayJan 04, 2023 10:10 am

QualityStocksNewsBreaks – SideChannel Inc. (SDCH) CEO Shares Purposeful Approach to Security Strategy in Hacker Valley Podcast

SideChannel’s (OTCQB: SDCH) CEO and Founder Brian Haugli was featured in a recent podcast produced by Hacker Valley Studio. The discussion centers around strategy and leadership in cybersecurity, with Haugli sharing what he has learned about a purposeful approach. “Strategy is not technology, it’s figuring out what you want to look like when you grow up, in a sense,” Haugli said, discussing his philosophy and the tenants in creating a strong security strategy. “Everyone jumps to the shiny object. What can I buy to go solve this problem? You never stop and question: Was that the first problem I was…

WednesdayJan 04, 2023 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Business Updates and Announces CEO’s Upcoming Speaking Engagements

BiondVax has released statistically significant results showing efficacy of its inhaled NanoAb as anti-COVID-19 therapy, as part of a preclinical proof-of-concept animal study The study was conducted in collaboration with the world-renowned institutes Fraunhofer Institute for Toxicology and Experimental Medicine (“ITEM”) and The University of Veterinary Medicine Hannover (“TiHo”) The technology is exclusively licensed from the prestigious Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Gottingen CEO Amir Reichman is scheduled to present in person at the Biotech Showcase (San Francisco – January 9th during JPM Healthcare conference week) and the BIO CEO & Investor Conference (New…

WednesdayJan 04, 2023 9:00 am

MetAlert, Inc. (MLRT) Recognizes Link Between Cognition in Aging Population and Use of Hearing Aids

MetAlert has, since its inception, sought to offer quality-of-life improvements to patients and caregivers dealing with Alzheimer’s, dementia, and autism (“ADA”) This focus has led to the company offering products and services within the GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring Also important is MetAlert’s offering of hearing aids, ranging from its flagship Hear IQ 4 rechargeable, app-controlled hearing aid, the NRBz noise-reducing buds, HearingVite, and the Ear-Ring Relief formula MetAlert understands the correlation between cognitive decline and hearing loss, with persons with hearing loss who wore devices performing better on cognitive scores…

TuesdayJan 03, 2023 3:10 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Strategic Board Appointment of Faith L. Charles, JD

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced its appointment of Faith L. Charles as chair of its board of directors. Since 2010, Charles has served as a corporate transactions and securities partner at the law firm of Thompson Hine, LLP. She currently leads the firm’s life sciences practice and co-heads the securities practice, advising public and emerging biotech and pharmaceutical companies in the U.S. and internationally. “The depth and breadth of knowledge, experience and network that Faith brings to…

TuesdayJan 03, 2023 2:53 pm

QualityStocksNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Forms Subsidiary with Focus on Immune Modulation Therapies

Aditxt (NASDAQ: ADTX) is a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system. The company today announced the formation of a U.S.-based subsidiary Adimune Inc. (“Adimune(TM)”) and its plans towards submission of a clinical trial application (“CTA”) for its immunotherapeutic technology drug candidate, ADI(TM)-100. The CTA application will request approval for Adimune to conduct the first-in-human study in psoriasis patients, beginning in the second half of 2023, with a second study also planned for type 1 diabetes. Joachim-Friedrich Kapp, M.D., Ph.D., a 30-year veteran of the pharmaceutical industry and former president…

TuesdayJan 03, 2023 2:28 pm

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Unveils New Lidar That Embodies Auto Industry’s Biggest Trends, Next-Gen Innovations

Cepton (NASDAQ: CPTN), a Silicon Valley innovator of high-performance lidar solutions, today announced the unveiling of its groundbreaking new lidar, the Vista(R)-X120 Plus. The world’s slimmest software definable, top-end automotive lidar for real-time adaptive 3D perception, the Vista-X120 Plus embodies the automotive industry’s biggest trends – safety, autonomy, software definability and electrification – and packs Cepton’s next-generation innovations. “The Vista-X120 Plus’ upgraded scanning mechanism enables extremely dense point clouds, while simplifying software algorithms for efficient sensor calibration and dynamic perception,” said Cepton’s CTO and Co-Founder Dr. Mark McCord. “Our proprietary ASIC chip enables optimal signal processing to further maximize lidar…

Site Search

Company Search